Focusing on Innovative Hepatology Ultrasound: Multiparametric Tools and Steatosis Assessment
Discover our webinar on the latest hepatology ultrasound advancements, and gain practical insights to advance your practice and improve patient outcomes!
As the name suggests, during the webinar “Focusing on Innovative Hepatology Ultrasound: Multiparametric Tools and Steatosis Assessment,” the speakers will provide a comprehensive overview of innovative multiparametric tools and methods for assessing liver steatosis and fibrosis, and share their expertise on applying these cutting-edge techniques in clinical practice.
Following the recent promotion by the World Federation for Ultrasound in Medicine and Biology (WFUMB) of guidance for the ultrasound assessment of liver fat content, which includes the recommended protocol for measuring the attenuation coefficient, this webinar, organized by the Canon Medical Academy, is designed to enhance your knowledge of standardized protocols and highlight the clinical value of multiparametric ultrasound in hepatology.
As the name suggests, during the webinar “Focusing on Innovative Hepatology Ultrasound: Multiparametric Tools and Steatosis Assessment,” the speakers will provide a comprehensive overview of innovative multiparametric tools and methods for assessing liver steatosis and fibrosis, and share their expertise on applying these cutting-edge techniques in clinical practice.
Following the recent promotion by the World Federation for Ultrasound in Medicine and Biology (WFUMB) of guidance for the ultrasound assessment of liver fat content, which includes the recommended protocol for measuring the attenuation coefficient, this webinar, organized by the Canon Medical Academy, is designed to enhance your knowledge of standardized protocols and highlight the clinical value of multiparametric ultrasound in hepatology.
Webinar | Focusing on Innovative Hepatology Ultrasound: Multiparametric Tools and Steatosis Assessment
Sign up for the webinar and join Prof. Valérie Vilgrain and Dr. Giovanna Ferraioli as they discuss the latest advancements in ultrasound techniques for hepatology, including the benefits and challenges of these innovative approaches.
Program
Program
- Introduction | Prof. Valérie Vilgrain
- Quantitative assessment of liver fat content with ultrasound | Dr. Giovanna Ferraioli
- Quantitative assessment of liver fibrosis with ultrasound | Prof. Valérie Vilgrain
- Live Q&A moderated by Prof. Valérie Vilgrain
- Understand the standardized ultrasound protocol for quantifying liver fat content
- Learn and understand ultrasound elastography methods for assessing liver fibrosis
- Understand the value of a comprehensive multiparametric approach
- Participate in the live Q&A to find answers to your questions
Speakers and Presentations
Moderator and speaker:
Prof. Valérie Vilgrain, MD, PhD
Head of Radiology Department
Beaujon Hospital, APHP
Clichy, France
Presentation: Quantitative assessment of liver fibrosis with ultrasound
Elastography is now considered a preferred non-invasive imaging technique for the clinical assessment of liver fibrosis. It provides liver stiffness measurements and is a surrogate biomarker for liver fibrosis. Ultrasound-based methods include point shear wave elastography (pSWE) and two-dimensional shear wave elastography (2D-SWE).
This webinar will detail the different elastography methods, discuss imaging quality criteria, demonstrate the diagnostic performance, and review the most common clinical applications.
Beaujon Hospital, APHP
Clichy, France
Presentation: Quantitative assessment of liver fibrosis with ultrasound
Elastography is now considered a preferred non-invasive imaging technique for the clinical assessment of liver fibrosis. It provides liver stiffness measurements and is a surrogate biomarker for liver fibrosis. Ultrasound-based methods include point shear wave elastography (pSWE) and two-dimensional shear wave elastography (2D-SWE).
This webinar will detail the different elastography methods, discuss imaging quality criteria, demonstrate the diagnostic performance, and review the most common clinical applications.
Discover More About the Speaker and Moderator
Speaker:
Dr. Giovanna Ferraioli, MD
Reference Doctor, Ultrasound Unit
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, Policlinico San Matteo, University of Pavia
Pavia, Italy
Presentation: Quantitative assessment of liver fat content with ultrasound
Early and accurate detection of liver steatosis is important because individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) are at increased risk for cardiovascular disease, liver-related events, and all-cause mortality compared to those without steatosis. Furthermore, the literature suggests that fibrosis progression may occur not only in patients with metabolic dysfunction-associated steatotic hepatitis (MASH) but also in those with “benign” liver steatosis. Therefore, tools that non-invasively quantify liver fat content are of great interest.
Currently, algorithms for quantitative estimation of liver fat content are commercially available, and most of them are based on the evaluation of the ultrasound (US) attenuation coefficient, which is the rate of amplitude loss of the US beam as it traverses tissue.
Several clinical studies, mostly performed with ATI (Canon Medical Systems), have demonstrated good accuracy and reproducibility of these new algorithms for fat quantification. However, the different cut-off values reported in the literature for detecting and grading liver steatosis highlight the need for a standardized measurement protocol that considers confounding factors such as measurement depth or ROI size.
The World Federation for Ultrasound in Medicine and Biology (WFUMB) recently promoted the publication of guidance for the US assessment of liver fat content, which includes the recommended protocol for measuring the attenuation coefficient.
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, Policlinico San Matteo, University of Pavia
Pavia, Italy
Presentation: Quantitative assessment of liver fat content with ultrasound
Early and accurate detection of liver steatosis is important because individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) are at increased risk for cardiovascular disease, liver-related events, and all-cause mortality compared to those without steatosis. Furthermore, the literature suggests that fibrosis progression may occur not only in patients with metabolic dysfunction-associated steatotic hepatitis (MASH) but also in those with “benign” liver steatosis. Therefore, tools that non-invasively quantify liver fat content are of great interest.
Currently, algorithms for quantitative estimation of liver fat content are commercially available, and most of them are based on the evaluation of the ultrasound (US) attenuation coefficient, which is the rate of amplitude loss of the US beam as it traverses tissue.
Several clinical studies, mostly performed with ATI (Canon Medical Systems), have demonstrated good accuracy and reproducibility of these new algorithms for fat quantification. However, the different cut-off values reported in the literature for detecting and grading liver steatosis highlight the need for a standardized measurement protocol that considers confounding factors such as measurement depth or ROI size.
The World Federation for Ultrasound in Medicine and Biology (WFUMB) recently promoted the publication of guidance for the US assessment of liver fat content, which includes the recommended protocol for measuring the attenuation coefficient.
Discover More About the Speaker
Discover More About the Moderator and Speakers
Prof. Valérie Vilgrain, MD, PhD Prof. Valérie Vilgrain is the Head of Radiology at Beaujon University Hospital, Clichy, Université Paris 7, France.
Prof. Vilgrain is currently a full professor of radiology at the University of Paris 7 Denis Diderot, France. She is a member of several national and international societies, including RSNA (Radiological Society of North America), ESR (European Society of Radiology), ESGAR (European Society of Gastro and Abdominal Radiology), and SFR (French Radiological Society).
Dr. Giovanna Ferraioli, MD Dr. Ferraioli is a researcher at the Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences at the University of Pavia, Italy.
She is a member of the Education Committee of the World Federation for Ultrasound in Medicine and Biology (WFUMB) and Chair of the WFUMB Steering Committee for “Multiparametric Ultrasound: Update to WFUMB 2018 elastography guidelines and consensus on fat quantification.” She is also a member of the AIUM-RSNA QIBA Pulse Echo Quantitative Ultrasound (PEQUS) Biomarker Committee, co-chair of the attenuation working group, and member of the ACR LIRADS Quantitative Imaging Work Group.
She is the head of the ultrasound section of the scientific editorial board of European Radiology, a subspecialty editor of the Journal of Ultrasound in Medicine, and a member of the editorial board of the World Journal of Gastroenterology, Ultrasound in Medicine and Biology, Diagnostics, and the Journal of Ultrasound.
Other webinars that may interest you
Disclaimers
Due to medical device regulatory reasons, not all products/services displayed on this Canon Medical Systems webpage are available in all countries or markets. Future availability of the products/service cannot also be guaranteed. Don't hesitate to contact your local Canon Medical Systems representative for further details.
